Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

83.40
Delayed Data
As of Jul 27
 +1.31 / +1.60%
Today’s Change
67.88
Today|||52-Week Range
92.85
-1.02%
Year-to-Date
Eli Lilly Names its Next CEO
Jul 27 / TheStreet.com - Paid Partner Content
S&P 500 Climbs as New Home Sales Hit Seven-Year High, McDonald's Sinks
Jul 26 / TheStreet.com - Paid Partner Content
3 Drugs Stocks Pushing Industry Growth
Jul 27 / TheStreet.com - Paid Partner Content
Lilly (LLY) Beats on Q2 Earnings & Revenue, Maintains View
Jul 26 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Announces Resignation of CEO John Lichleiter, CNBC Reports
Jul 27 / TheStreet.com - Paid Partner Content
'Exactly the Trajectory We Want to be On,' Eli Lilly (LLY) CEO Lechleiter Tells CNBC
Jul 26 / TheStreet.com - Paid Partner Content
Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure
Jul 27 / TheStreet.com - Paid Partner Content
Eli Lilly (LLY) Stock Rising After Mixed Q2 Results
Jul 26 / TheStreet.com - Paid Partner Content
Stocks Trade Mixed as Crude Settles Under $43
Jul 26 / TheStreet.com - Paid Partner Content
Eli Lilly (LLY) Tops on Q2 Earnings & Revenues
Jul 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close82.09
Today’s open82.25
Day’s range82.15 - 83.59
Volume4,057,228
Average volume (3 months)4,137,708
Market cap$90.7B
Dividend yield2.45%
Data as of 4:02pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+3.74%
Earnings growth (next 5 years)+13.40%
Revenue growth (last year)+1.75%
P/E ratio38.4
Price/Sales4.50
Price/Book6.23

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+11.29+4.54%
CELGCelgene+1.93+1.82%
AZNAstraZeneca+0.63+2.04%
ABBVAbbVie+0.45+0.70%
Data as of 4:02pm ET, 07/27/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.94
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Partner Offers

Search for Jobs